Brixton Biosciences
PrivateLast Round
Grant
Oct 24, 2024
Total Funding Raised
$37M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Brixton Biosciences operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Grant round in October 2024.
Brixton Biosciences is a biotechnology company developing innovative, drug-free injectable therapies for chronic and acute pain management.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Brixton Biosciences Comparables
Compare Brixton Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Thermaquil Inc. | 74% | |
| Pacira BioSciences | 73% | |
| Neuros Medical | 72% |
For institutional investors. Book with your work email.
Brixton Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 24, 2024 | ||||
| Series B | May 14, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Brixton Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Health Investors | Series B |
| NIH RADx | Grant |
| Sparta Group LLC | Series B |
| Pritzker Vlock Family Office | Series B |
| Schooner Capital | Series B |
| Catalyst Health Ventures | Series B |
| Excelestar Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 60% MoM.
- Jul 27, 2026
Monthly visitors increased 66% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventOct 29, 2026
Brixton Biosciences, Inc. attends the Annual Meeting of the American Association of Hip and Knee Surgeons (AAHKS) in Texas in Nov '26, where pivotal Reneurx Nerve-Selective Therapy data is presented during a podium presentation.
For institutional investors. Book with your work email.
Brixton Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Brixton Biosciences's valuation, stock price, and market status.
Is Brixton Biosciences a public or private company?
Brixton Biosciences is a private company.
What is the current stock price of Brixton Biosciences?
Brixton Biosciences is a private company, so its shares have no public market price. Caplight tracks Brixton Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Brixton Biosciences worth (valuation)?
Valuation information for Brixton Biosciences is not publicly available.
Can I buy Brixton Biosciences stock?
Brixton Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Brixton Biosciences's last funding round?
Brixton Biosciences's most recent funding round was Grant on October 24, 2024.
Who are the main investors in Brixton Biosciences?
Key investors in Brixton Biosciences include Schooner Capital.
Will Brixton Biosciences IPO soon?
No public IPO plans have been announced for Brixton Biosciences.
How can I track Brixton Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Brixton Biosciences's shares on secondary markets.